ATE551430T1 - Glimepirid- und insulin-induzierte glykosylphosphatidylinositol-spezifische phospholipase c-regulierung - Google Patents

Glimepirid- und insulin-induzierte glykosylphosphatidylinositol-spezifische phospholipase c-regulierung

Info

Publication number
ATE551430T1
ATE551430T1 AT05707425T AT05707425T ATE551430T1 AT E551430 T1 ATE551430 T1 AT E551430T1 AT 05707425 T AT05707425 T AT 05707425T AT 05707425 T AT05707425 T AT 05707425T AT E551430 T1 ATE551430 T1 AT E551430T1
Authority
AT
Austria
Prior art keywords
glimepiride
glycosylphosphatidylinositol
insulin
induced
regulation
Prior art date
Application number
AT05707425T
Other languages
English (en)
Inventor
Guenter Mueller
Wendelin Frick
Rudolf Schneider
Original Assignee
Sanofi Aventis Deutschland
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Aventis Deutschland filed Critical Sanofi Aventis Deutschland
Application granted granted Critical
Publication of ATE551430T1 publication Critical patent/ATE551430T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/02Separating microorganisms from their culture media
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6564Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms
    • C07F9/6571Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus and oxygen atoms as the only ring hetero atoms
    • C07F9/657163Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus and oxygen atoms as the only ring hetero atoms the ring phosphorus atom being bound to at least one carbon atom
    • C07F9/657181Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus and oxygen atoms as the only ring hetero atoms the ring phosphorus atom being bound to at least one carbon atom the ring phosphorus atom and, at least, one ring oxygen atom being part of a (thio)phosphonic acid derivative
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/34Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90Enzymes; Proenzymes
    • G01N2333/914Hydrolases (3)
    • G01N2333/916Hydrolases (3) acting on ester bonds (3.1), e.g. phosphatases (3.1.3), phospholipases C or phospholipases D (3.1.4)

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Diabetes (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Endocrinology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biophysics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Physics & Mathematics (AREA)
  • Emergency Medicine (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AT05707425T 2004-02-20 2005-02-16 Glimepirid- und insulin-induzierte glykosylphosphatidylinositol-spezifische phospholipase c-regulierung ATE551430T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP04003897A EP1566447A1 (de) 2004-02-20 2004-02-20 Glimepiride- und Insulin-induzierte Glycosylphospatidylinositol-spezifische Phospholipase C Regulation
PCT/EP2005/001553 WO2005080587A2 (en) 2004-02-20 2005-02-16 Glimepiride- and insulin-induced glycosylphosphatidylinositol-specific phospholipase c regulation

Publications (1)

Publication Number Publication Date
ATE551430T1 true ATE551430T1 (de) 2012-04-15

Family

ID=34707348

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05707425T ATE551430T1 (de) 2004-02-20 2005-02-16 Glimepirid- und insulin-induzierte glykosylphosphatidylinositol-spezifische phospholipase c-regulierung

Country Status (11)

Country Link
EP (2) EP1566447A1 (de)
JP (3) JP5514395B2 (de)
KR (1) KR101191676B1 (de)
CN (1) CN1981048B (de)
AT (1) ATE551430T1 (de)
AU (1) AU2005215886B2 (de)
BR (1) BRPI0507889A (de)
CA (1) CA2556868C (de)
IL (3) IL177257A (de)
SG (1) SG135186A1 (de)
WO (1) WO2005080587A2 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10801003B2 (en) 2016-06-03 2020-10-13 Lonza Ltd Single use bioreactor

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1244546B (it) * 1991-02-01 1994-07-15 Mediolanum Farmaceutici Spa Analoghi del fosfatidilinositolo inibitori della fosfolipasi c fosfatidilinositolo-specifica
US5519163A (en) * 1993-10-15 1996-05-21 Merck & Co., Inc. Inhibitors of phosphoinositide-specific phospholipase C
JPH07206887A (ja) * 1994-01-24 1995-08-08 Asahi Chem Ind Co Ltd 新規ホスホリパーゼc阻害物質am6211及びその製造法
US20030190651A1 (en) * 2000-07-31 2003-10-09 Sophia Kossida Regulation of human phosphatidylinositol-specific phospholipase c-like enzyme
MXPA03002934A (es) * 2000-10-10 2004-05-04 Univ North Carolina Composiciones y metodos para aumentar la permeabilidad paracelular a traves de las barreras epiteliales y endoteliales.

Also Published As

Publication number Publication date
KR101191676B1 (ko) 2012-10-18
WO2005080587A2 (en) 2005-09-01
EP1718757A2 (de) 2006-11-08
JP2011140492A (ja) 2011-07-21
JP5337825B2 (ja) 2013-11-06
SG135186A1 (en) 2007-09-28
JP5514395B2 (ja) 2014-06-04
JP2007522811A (ja) 2007-08-16
AU2005215886B2 (en) 2010-07-22
WO2005080587A3 (en) 2006-12-28
JP2012135318A (ja) 2012-07-19
BRPI0507889A (pt) 2007-08-07
IL177257A0 (en) 2006-12-10
IL202543A (en) 2013-02-28
AU2005215886A1 (en) 2005-09-01
EP1718757B1 (de) 2012-03-28
CN1981048B (zh) 2014-06-18
EP1566447A1 (de) 2005-08-24
IL177257A (en) 2010-12-30
CA2556868C (en) 2013-10-15
CN1981048A (zh) 2007-06-13
IL202544A (en) 2011-02-28
KR20060131845A (ko) 2006-12-20
CA2556868A1 (en) 2005-09-01

Similar Documents

Publication Publication Date Title
WO2005080551A3 (en) Stem cells
DE602006014812D1 (de) Lostridientoxinaktivität
DE60332157D1 (de) Expansion erneuerbarer stammzellpopulationen
MY142818A (en) Process for preparing alkyl (meth)acrylates
EA200702541A1 (ru) Полиморфы этилового эфира 3-[(2-{[4-(гексилоксикарбониламиноиминометил)фениламино]метил}-1-метил-1н-бензимидазол-5-карбонил)пиридин-2-иламино]пропионовой кислоты
DK1962095T3 (da) Fremgangsmåde til øgning af lysemission fra en kemiluminescent reaktion
SV2008002551A (es) Inhibidores de la fosfolipasa a2 citosolica ref.: wyth0122-503/am101816(187007)
DE602005009938D1 (de) Polymere reaktionsprodukte substituierter aminosiloxane
PE20110207A1 (es) Tetrahidrocinolinas como inhibidores de la 11-beta-hsd1 para la diabetes
WO2006044747A3 (en) P27 ubiquitination assay and methods of use
NO20070254L (no) Kationiske polymerer som inneholder 2-hydroxyethyl- metakrylsyre som akselerator for ASA liming
DE602004009030D1 (de) Phenyltetrazol-Verbindungen
DE602006008720D1 (de) Verfahren zur Herstellung von Dialkylcarbonaten
ECSP045215A (es) Metabolitos del ácido (3-{[4-terc-butilbencil)-(piridin-3-sulfonil)amino]metil}fenoxi) acético
ATE551430T1 (de) Glimepirid- und insulin-induzierte glykosylphosphatidylinositol-spezifische phospholipase c-regulierung
AR051936A1 (es) Proceso para la preparacion de pirazoles
ATE474613T1 (de) Genpistole mit niederdruckgasbeschleunigung
BRPI0411653A (pt) anodo para bateria
DK2265580T3 (da) Hidtil ukendt fremgangsmåde til fremstillingen af sulfonylpyrroler som HDAC-inhibitorer
EA200970219A1 (ru) Система топливных элементов и способ запуска этой системы
DK1807401T3 (da) Fremgangsmåde til fremstilling af phenyl-2-pyrimidinylketoner samt deres nye mellemprodukter
TH87444A (th) ตัวยับยั้งต่างๆ ของไซโตโซลิกฟอสโฟไลเพส a2
BRPI0407685A (pt) bateria que contém material fibroso
WO2006069000A3 (en) Klf2 as a mediator of statin activity
DK1238057T3 (da) Fremgangsmåde til produktion af vedhæftende dyreceller